Stay updated with breaking news from Tumor Excision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The imaging agent and visualization system will be an adjunct to standard of care to reduce residual cancer in the lumpectomy cavity during initial surgery.
Intracavity, real-time assessment of margins using a novel imaging agent and visualization system may improve complete resection rates, new findings show.
The system is considered effective at identifying residual breast cancer following surgical resection.
Novel optical imaging agent highlights cancerous tissue during initial lumpectomy to enable a more complete resection as part of the investigational Lumicell Direct Visualization SystemÂ